scispace - formally typeset
V

Vojtěch Kubíček

Researcher at Charles University in Prague

Publications -  62
Citations -  2087

Vojtěch Kubíček is an academic researcher from Charles University in Prague. The author has contributed to research in topics: DOTA & Phosphinate. The author has an hindex of 23, co-authored 57 publications receiving 1864 citations. Previous affiliations of Vojtěch Kubíček include Delft University of Technology & Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes

TL;DR: The ligand types and structures of their complexes on one side and a set of the physico-chemical parameters governing properties of the CAs on the other side are discussed and the solid-state structures of lanthanide(III) complexes of open-chain and macrocyclic ligands and their structural features are compared.
Journal ArticleDOI

A Triazacyclononane‐Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric 68Ga Tracers for Positron Emission Tomography

TL;DR: For application in positron emission tomography (PET), PrP9, a N,N',N''-trisubstituted triazacyclononane with methyl(2-carboxyethyl)phosphinic acid pendant arms, was developed as (68)Ga(3+) complexing agent, which for the first time can be directly used for labeling purposes.
Journal ArticleDOI

Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.

TL;DR: The kinetic inertness of both chelates is extremely high and approves the application of Ga(3+) complexes of such DOTA-like ligands in molecular imaging.
Journal ArticleDOI

Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.

TL;DR: Complex formation studies in acidic solutions indicate that Ga(3+) complexes of the phosphinate ligands are formed quickly (minutes) and quantitatively even at pH <2.5, and the discussed TRAP ligANDs are suitable alternatives for the development of (68)Ga radiopharmaceuticals.
Journal ArticleDOI

PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study.

TL;DR: [Ga]BPAMD seems to be an ideal PET/CT tracer to plan and monitor bisphosphonate therapy in several bone disorders like osteoporosis, osteitis deformans, bone metastases, multiple myeloma, osteogenesis imperfecta, etc. and also to monitor radionuclide therapy for palliation of bone pain.